Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of active lupus nephritis with MMF, tacrolimus, or cyclophosphamide
ChiCTR-TRC-10000896Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Jan 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in lupus nephritis (LN) comparing MMF arm, Tacrolimus arm and Cyclophosphamide induction + azathioprine maintenance arm (3 arms). Primary endpoint: Complete remission rate. Started Jan 2010; status: recruiting.
02
Drugs
mycophenolate mofetiltacrolimuscyclophosphamideazathioprine
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on ChiCTR-TRC-10000896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000896.